- Home
- PPBT
PPBT
Purple Biotech Ltd.
as 11-15-2024 1:37pm EST
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.
Upcoming Earnings Alert:
Get ready for potential market movements as Purple Biotech Ltd. PPBT prepares to release earnings report on 19 Nov 2024.
| Founded: | 2010 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 9.2M | IPO Year: | N/A |
| Target Price: | $126.50 | AVG Volume (30 days): | 61.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.06 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.50 - $23.20 | Next Earning Date: | 11-19-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Purple Biotech Ltd. News
PPBT Breaking Stock News: Dive into PPBT Ticker-Specific Updates for Smart Investing
GlobeNewswire
7 hours ago
Purple Biotech Reports Third Quarter 2024 Financial Results
TipRanks
10 days ago
Purple Biotech Unveils Promising Biomarker for Cancer Therapy
GlobeNewswire
11 days ago
Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of Death
GlobeNewswire
21 days ago
Purple Biotech Presents New Data for its Novel Tri-Specific T Cell and NK Cell Engagers Antibody Platform, CAPTN-3, at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
TipRanks
a month ago
Purple Biotech Unveils CAPTN-3 Cancer Therapy
GlobeNewswire
a month ago
Purple Biotech to Present Data for its Tri-Specific Antibody Platform—CAPTN-3—at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
GlobeNewswire
2 months ago
Purple Biotech Reports Additional Positive Interim Data from its Randomized Phase 2 Study with its Lead Oncology Therapeutic Candidate CM24
TipRanks
2 months ago
Upcoming Stock Splits This Week (September 16 to September 20) – Stay Invested
Compare PPBT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PPBT Purple Biotech Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.